Carboplatin Injection, Solution
Product Images NDC 0703-4248

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Carboplatin (NDC 0703-4248). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Teva Parenteral Medicines, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (Carboplatin Injection Solution A077269 1)

Chemical structure of carboplatin showing the platinum atom coordinated with two ammine groups and a bidentate cyclobutane dicarboxylate ligand.*

FDA Label Image

Carton 50 mg/5 mL (Carboplatin Injection Solution A077269 2)

Carton label for Carboplatin Injection 50 mg/5 mL (10 mg/mL) sterile aqueous solution in a 5 mL multi-dose vial. The label indicates it is a cytotoxic agent for intravenous use and is manufactured by Pharmachemie B.V., Netherlands for Teva Pharmaceuticals USA, Inc. It includes storage instructions and a barcode.*

FDA Label Image

Carton 150 mg/15 mL (Carboplatin Injection Solution A077269 3)

Carboplatin Injection 10 mg/mL (150 mg/15 mL) sterile aqueous solution in a 15 mL multi-dose vial, labeled as a cytotoxic agent. The packaging label includes storage instructions to protect from light and store at 20° to 25°C. Manufactured by Pharmachemie B.V. in the Netherlands and labeled for Teva Pharmaceuticals USA, Inc. Provides warnings about no preservatives and directs pharmacists to dispense with an attached patient information leaflet.*

FDA Label Image

Carton 450 mg/45 mL (Carboplatin Injection Solution A077269 4)

Packaging label for Carboplatin Injection 450 mg/45 mL (10 mg/mL) sterile aqueous solution in a 45 mL multi-dose vial. The label indicates it is a cytotoxic agent for intravenous use, manufactured for Teva Pharmaceuticals USA, Inc. It includes storage instructions, barcode, and caution to protect from light.*

FDA Label Image

Carton 600 mg/60 mL (Carboplatin Injection Solution A077269 5)

Packaging label for Carboplatin Injection 600 mg/60 mL (10 mg/mL) sterile aqueous solution in a 60 mL multi-dose vial. The label indicates it is a cytotoxic agent for intravenous use. Manufactured for Teva Pharmaceuticals USA, Inc. by Pharmachemie B.V., Haarlem, The Netherlands. Storage instructions specify 20° to 25°C, protection from light, and retention in carton until use. Contains no preservatives and includes mannitol as an inactive ingredient.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.